RF vs SBFMW
RF (RF) versus Sunshine Biopharma Inc. Warrant (SBFMW) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Sunshine Biopharma Inc. Warrant (SBFMW) common stock listed on NASDAQ.
RF does not have a complete income-statement cache yet.
Latest reported SBFMW revenue for 2024-12-31 was $34.9M. Net income was -$5.1M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. SBFMW currently screens at market cap $0.
RF currently screens at market cap $0. SBFMW currently screens at market cap $0.
Not investment advice. Open the RF and SBFMW stock pages for the full models.
Not investment advice.